Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET A receptor antagonist

By Yuyama H.   Sanagi M.   Koakutsu A.   Mori M.   Fujimori A.   Harada H.   Sudoh K.   Miyata K.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite

Ameliorating effect of an endothelin ET A receptor antagonist on renal function of DOCA-salt hypertensive rats

By Matsumura Y.   Hashimoto N.   Fujita K.   Morimoto S.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 65-69

Elsevier

Access to resources Recommend Favorite

Pharmacology of A-216546: a highly selective antagonist for endothelin ET A receptor

By Wu-Wong J.R.   Dixon D.B.   Chiou W.J.   Dayton B.D.   Novosad E.I.   Adler A.L.   Wessale J.L.   Calzadilla S.V.   Hernandez L.   Marsh K.C.   Liu G.   Szczepankiewicz B.   von Geldern T.W.   Opgenorth T.J.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 189-201

Elsevier

Access to resources Recommend Favorite

Protective effect of DS-4574, a peptidoleukotriene receptor antagonist, against endotoxin-induced intestinal injury in rats

By Tabuchi Y.   Furuhama K.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 281-284

Elsevier

Access to resources Recommend Favorite

The effect of the endothelin ET A receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction

By Jones R.D.   Wanstall J.C.   Gambino A.   Morice A.H.  

European Journal of Pharmacology, Vol. 374, Iss. 3, 1999-06 ,pp. : 367-375

Elsevier

Access to resources Recommend Favorite